Device brand name · 80frn
Symbiq 3 13 Dual Cha: medical device reports filed with FDA
346 reports name it, 2012–2015. Manufacturer given most often on reports: Hospira Costa Rica. Product code FRN.
- 346
- device reports naming the brand
- 0% of all MAUDE reports · about 25 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 93.1%
- classified as malfunction
- 98.5% across the product code
- 2%
- classified as death, as reported
- 7 reports · not verified by FDA
FDA's MAUDE database holds 346 reports that name the brand "Symbiq 3 13 Dual Cha" (80frn), received between July 2012 and April 2015; the manufacturer given most often on reports is Hospira Costa Rica. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (93.1%), injury (3.8%) and death (2%); across all pump, infusion reports (product code FRN) death is recorded in 0.1% and malfunction in 98.5%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are failure to sense (56.1%), device inoperable (30.1%) and overheating of device (3.2%). The patient problems coded most often are no patient involvement, sepsis and low blood pressure/ hypotension. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Symbiq 3 13 Dual Cha was received in the five years to August 2026; the latest was received in April 2015.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 1,831,109 reports carrying product code FRN. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Failure to sense | 194 | 56.1% | 0.9% |
| Device inoperablethe device could not be used | 104 | 30.1% | 0.3% |
| Overheating of device | 11 | 3.2% | 0% |
| Device alarm system | 4 | 1.2% | 2.8% |
| Breakthe device broke | 3 | 0.9% | 8.5% |
| Insufficient flow or under infusion | 3 | 0.9% | 0.8% |
| Loss of powerthe device lost power | 3 | 0.9% | 0.1% |
| Battery problema problem with the battery | 2 | 0.6% | 1.2% |
| Bent | 2 | 0.6% | 0.1% |
| Device displays incorrect message | 2 | 0.6% | 9.3% |
| Failure to calibrate | 2 | 0.6% | 0.9% |
| Improper flow or infusion | 2 | 0.6% | 0.5% |
| Inaccurate delivery | 2 | 0.6% | 0.4% |
| No audible alarm | 2 | 0.6% | 0.2% |
| Smoking | 2 | 0.6% | 0% |
| Charred | 1 | 0.3% | 0% |
| Failure to fire | 1 | 0.3% | 0% |
| Melted | 1 | 0.3% | 0% |
| Occlusion within devicethe device blocked | 1 | 0.3% | 0.6% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| No patient involvement | 117 | 33.8% |
| Sepsisa severe body-wide response to infection | 11 | 3.2% |
| Low blood pressure/ hypotension | 7 | 2% |
| Deaththe patient died; cause not stated by this term | 4 | 1.2% |
| Hypoglycemialow blood sugar | 1 | 0.3% |
| Renal failurekidney failure | 1 | 0.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Symbiq 3 13 Dual Cha | Product code FRN | All MAUDE reports |
|---|---|---|---|
| Reports | 346 | 1,831,109 | 26,136,888 |
| Share of that pool | — | 0% | 0% |
| Classified as death, per 1,000 reports | 20 | 1 | 9 |
| Classified as injury | 3.8% | 1.3% | 36.2% |
| Classified as malfunction | 93.1% | 98.5% | 62.3% |
| Filed by the manufacturer | 100% | 99.1% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code FRN
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Alaris Pump Module | 684,522 | 0 | 0% |
| Alaris System | 422,501 | 33,692 | 0% |
| 8100 Alaris Pump Module | 163,620 | 0 | 0% |
| Spectrum Infusion Pump | 147,363 | 15 | 0% |
| 8015 Alaris System Pc Unit | 54,162 | 0 | 0% |
| Alaris System Pc Unit | 24,066 | 0 | 0% |
| 8110 Alaris Syringe Pump | 22,434 | 0 | 0% |
| Colleague | 21,763 | 0 | 0% |
| Reservoir 3ML MMT-332A | 19,914 | 2,008 | 0.4% |
| Reservoir 3ml | 16,407 | 0 | 0.8% |
| Flogard | 15,668 | 0 | 0% |
| Colleague Volumetric Infusion Pump | 13,678 | 0 | 0.1% |
| Colleague Pre P1 7 | 13,103 | 0 | 0% |
| CADD-Solis VIP Ambulatory Infusion Pump | 11,721 | 3,471 | 0.1% |
| Intermate | 8,261 | 47 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Symbiq 3 13 Dual Cha reports
How many FDA reports name Symbiq 3 13 Dual Cha?
346 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (93.1%), injury (3.8%) and death (2%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
failure to sense (56.1%), device inoperable (30.1%), overheating of device (3.2%), device alarm system (1.2%) and break (0.9%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Symbiq 3 13 Dual Cha was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.